Serum soluble TH cell activity markers and high-sensitivity C-reactive protein in multiple-trigger wheezers.
Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: anne.kotaniemi-syrjanen@fimnet.fi.
Anne
A
Kotaniemi-Syrjänen
ISLAB Laboratory Centre, Kuopio, Finland.
Weronika
W
Delezuch
Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
L Pekka
LP
Malmberg
ISLAB Laboratory Centre, Kuopio, Finland.
Kari
K
Punnonen
HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Irma H
IH
Matinlauri
Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Anna S
AS
Pelkonen
Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Mika J
MJ
Mäkelä
D000485:Allergens / Q000276:immunology; D001249:Asthma / Q000175:diagnosis* / Q000276:immunology; D015415:Biomarkers / Q000097:blood* / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism; D002648:Child; D018819:Dipeptidyl Peptidase 4 / Q000097:blood*; D004359:Drug Therapy, Combination; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D000068298:Fluticasone / Q000627:therapeutic use; D006801:Humans; D017730:Ki-1 Antigen / Q000097:blood*; D008213:Lymphocyte Activation; D008297:Male; D012135:Respiratory Sounds; D000068299:Salmeterol Xinafoate / Q000627:therapeutic use; D013147:Spirometry; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*; D016896:Treatment Outcome
D000485:Allergens; D015415:Biomarkers; D017730:Ki-1 Antigen; D000068299:Salmeterol Xinafoate; D002097:C-Reactive Protein; D000068298:Fluticasone; D018819:Dipeptidyl Peptidase 4